Common questions
CJC-1295 Ipamorelin: your questions, answered straight and cited.
The questions people actually ask, with short answers tied to the published record. No dosing guidance.
Does Ipamorelin reduce belly fat?
Not proven for ipamorelin itself — the read-across comes from a related GHRH analogue. A 2026 meta-analysis of five randomized trials of tesamorelin found significant reductions in visceral (belly) fat of −27.71 cm² and liver fat of −4.28%, plus more lean mass [10]. That shows the GHRH mechanism can move visceral fat in humans; ipamorelin's own belly-fat effect has not been quantified in a trial.
Does CJC-1295 / Ipamorelin cause weight gain?
It can cut both ways. A review of GH secretagogues found them generally well tolerated, with raised blood glucose from lower insulin sensitivity as the chief concern [4]. Separately, ipamorelin increased body fat, leptin and food intake in GH-intact mice through an appetite pathway [9] — so the hunger bump people report could nudge weight up if intake rises.
Does Ipamorelin burn fat?
Indirectly and unproven for the peptide alone. The GHRH-axis read-across is encouraging — tesamorelin reduced visceral and hepatic fat across five randomized trials [10] — and raising GH/IGF-1 supports fat metabolism. But ipamorelin itself raised adiposity via appetite in one mouse model [9], so 'burns fat' is not an established, clean effect for it.
Will CJC-1295 / Ipamorelin give good results with weight loss and muscle building?
The upstream signal is real; the body-composition payoff for this fixed pair is unproven. A single CJC-1295 (DAC) dose raised GH 2- to 10-fold for six-plus days and IGF-1 for nine to eleven days in healthy adults [1] — the axis muscle and fat changes flow from. But no controlled trial has measured weight or muscle outcomes for the combination, so results are extrapolated, not demonstrated.
Does Ipamorelin make you hungry / increase appetite?
Yes — that is mechanistically expected. Ipamorelin acts on the ghrelin receptor, the body's hunger signal, and in GH-intact mice it raised food intake and leptin via a GH-independent route [9]. Increased appetite soon after dosing is also one of the most frequently reported community effects, generally described as milder than with older GH-releasing peptides.
What is CJC-1295 / Ipamorelin good for?
In the literature, each half raises the body's own GH and IGF-1 — CJC-1295 for days at a time [1], ipamorelin as a clean selective pulse [2] — and the two together release GH synergistically in humans [3]. Research-use communities pursue it for body composition, recovery, and sleep, but the fixed blend itself has no controlled-trial evidence for any of these.
What are the bad side effects of CJC-1295 and Ipamorelin?
Ipamorelin's design helps here: it did not raise ACTH or cortisol above GHRH-stimulated levels even at over 200 times the GH-releasing dose [2]. The class's documented concerns are raised blood glucose from reduced insulin sensitivity [4], plus GH-related fluid retention, carpal-tunnel-type symptoms, and joint aches. Community reports add injection-site reactions, flushing, and water retention.
How long do CJC-1295 and Ipamorelin take to work?
Biochemically, fast. A single CJC-1295 (DAC) dose raised GH within days and IGF-1 1.5- to 3-fold for nine to eleven days, staying elevated up to 28 days after multiple doses [1]; ipamorelin's GH peak hits around 40 minutes post-dose [2]. Felt effects like sleep are reported in the first week or two by the community, but that is anecdote, not trial timing.
How many mg of CJC-1295 and Ipamorelin should I take?
This site gives no human dosing, and there is no validated dose for the fixed combination — it has never been through a dosing trial. The literature only reports research doses by species and route; for example, CJC-1295 (DAC) was studied at 30 to 90 µg/kg subcutaneously in human Phase 1 pharmacokinetics [1]. That is an observation, not a recommendation.
Does CJC-1295 raise testosterone?
That is not what the CJC-1295 literature measures. Its documented action is on the GH/IGF-1 axis — a single dose raised GH 2- to 10-fold for six-plus days and IGF-1 for nine to eleven days in healthy adults [1]. No controlled study attributes a testosterone increase to CJC-1295; claims to that effect are not supported by the published pharmacology.
What are the downsides to CJC-1295 / Ipamorelin?
The biggest downside is missing evidence: the fixed blend has never been trialed, and ipamorelin has no published human pharmacokinetics. On effects, expect the GH-class issues — glucose elevation from reduced insulin sensitivity [4] and fluid-related symptoms — plus community-reported injection-site reactions and flushing. Ipamorelin's selectivity (no ACTH/cortisol rise [2]) is a genuine upside by comparison.
Which is better, Sermorelin or Ipamorelin?
They are different tools, not rivals. Sermorelin is a GHRH analogue (the GHRH-side signal); ipamorelin is a GHRP, a selective ghrelin-receptor agonist (the other signal) [2]. In the logic of this pairing they are complementary — a GHRH plus a GH-releasing-peptide signal release GH synergistically [3]. 'Better' depends on which arm you mean; neither is FDA-approved for body-composition use.
Can you take both Sermorelin and Ipamorelin together?
Combining a GHRH analogue with a GHRP is the exact mechanism this whole pairing rests on. In normal men, submaximal GHRP doses combined with GHRH released GH synergistically through independent mechanisms [3]. That said, no controlled trial has validated any specific sermorelin-plus-ipamorelin protocol in humans, so the synergy is established in principle, not as a tested regimen.
Is Tesamorelin better than Ipamorelin?
For proven human results, tesamorelin has the evidence ipamorelin lacks: five randomized trials show reduced visceral and hepatic fat and increased lean mass [10]. But they are different signals — tesamorelin is a GHRH analogue, ipamorelin a ghrelin-receptor peptide [2] — so it is less 'better' than 'better-evidenced for body composition'. The two are often discussed as complementary arms, not substitutes.
Is Ipamorelin stronger than Sermorelin?
They are not measured on the same scale, so 'stronger' is the wrong frame. Ipamorelin is a selective ghrelin-receptor agonist that releases GH potently without raising stress hormones even far above its GH-releasing dose [2]; sermorelin is a GHRH analogue acting on a different receptor. Their real value, per the human data, is combined and synergistic [3] — not one out-muscling the other.
Which is safer, Sermorelin or Ipamorelin?
Neither has a long-term human safety database, and both share the GH-class concerns — chiefly raised blood glucose from reduced insulin sensitivity [4]. Ipamorelin has one notable safety point in its favor mechanistically: it did not raise ACTH or cortisol above GHRH-stimulated levels even at over 200 times the GH-releasing dose [2]. Neither is FDA-approved, which is itself a safety-data limitation.
What is CJC-1295 / Ipamorelin?
It is a research pairing of two peptides that both raise your own growth hormone by different routes: CJC-1295, a long-acting GHRH analogue [1], and ipamorelin, a selective ghrelin-receptor (GHS-R1a) agonist [2]. Hit together, the two signals release GH supra-additively in humans [3]. Neither is FDA-approved, and the fixed mix has never been clinically trialed.
How much CJC-1295 / Ipamorelin should I take?
No amount is recommended here — this is an editorial digest, not medical guidance, and there is no validated human dose for the combination. The literature reports only research doses by species and route (for instance, CJC-1295 (DAC) at 30 to 90 µg/kg subcutaneously in Phase 1 pharmacokinetics [1]); that describes a study, not a protocol for any person.
Is CJC-1295 / Ipamorelin safe?
There is no long-term safety database for the fixed combination, because it has never been trialed. The GH-secretagogue class looks well tolerated short-term, with raised blood glucose the chief concern and long-term cancer and mortality data still needed [4]. Ipamorelin's selectivity — no ACTH or cortisol rise even at high multiples of its GH dose [2] — is a favorable point, but unverified research-grade purity adds real risk.
Does CJC-1295 / Ipamorelin work?
For raising GH and IGF-1, yes — that is well documented: a single CJC-1295 (DAC) dose raised GH 2- to 10-fold for six-plus days and IGF-1 for nine to eleven days in healthy adults [1], and ipamorelin releases GH selectively [2]. Whether it 'works' for fat loss or muscle in humans is unproven for the fixed blend, which has no controlled-trial outcomes.
Is Ipamorelin FDA approved?
No. Neither ipamorelin nor CJC-1295 is FDA-approved for any human indication; both are sold only as research chemicals. A review of GH secretagogues notes the class is generally well tolerated short-term but emphasizes that long-term and large-population safety data are lacking [4] — part of why approval has not been granted.
How to reconstitute CJC-1295 / Ipamorelin (5mg)?
This site gives no preparation instructions. In research-handling terms, lyophilised peptide is reconstituted with bacteriostatic water (sterile water with 0.9% benzyl alcohol), then kept refrigerated at 2–8 °C, protected from agitation and freeze-thaw, because aqueous peptide degrades over weeks via deamidation [5]. That is laboratory context only, not a how-to for any individual.